Fate Therapeutics FATE
NASDAQ FATE
$2.09 +0.03 (+1.21%)
As of: Oct 21, 2026 · 2:25 PM EDT

Fate Therapeutics (FATE) Interest Paid (2018 - 2019)

Updated

Analysis

Fate Therapeutics (FATE) Interest Paid (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn -
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn -
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn -
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn -
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn 1.07 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 1.25 Bn
10 Fate Therapeutics 251.03 Mn 97.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 1.35 Mn
Sep 30, 2019 312,000.00
Jun 30, 2019 317,000.00
Mar 31, 2019 309,000.00
Dec 31, 2018 313,000.00
Sep 30, 2018 316,000.00
Jun 30, 2018 314,000.00
Mar 31, 2018 299,000.00
API Access

Fate Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=FATE&period=max&api_key=YOUR_API_KEY